RCMI Coordinating Center (RCMI CC) Header Logo

Adebayo Oyekan

TitleDr.
Faculty RankAssociate Professor
InstitutionTexas Southern University
DepartmentDepartment of Pharmaceutical Science
AddressTexas Southern University
3100 Cleburne Street
Houston TX 77004
Phone7133134341
Fax7133134342
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    UH1HL003674     (OYEKAN, ADEBAYO O.)Sep 30, 1996 - Aug 31, 2006
    NIH
    TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARD
    Role: Principal Investigator
    R25HL003674     (OYEKAN, ADEBAYO O.)Sep 30, 1996 - Aug 31, 2013
    NIH
    TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARD
    Role: Principal Investigator
    R01HL059884     (OYEKAN, ADEBAYO O.)Jun 1, 1998 - May 31, 2005
    NIH
    20-HETE IN NO-MEDIATED REGULATION OF RENAL FUNCTION
    Role: Principal Investigator
    P30HL107272     (OYEKAN, ADEBAYO O.)Jul 1, 2011 - Apr 30, 2015
    NIH
    CENTER FOR HEALTH DISPARITIES RESEARCH IN CARDIOVASCULAR DISEASES & HIV
    Role: Principal Investigator
    G12MD007605     (WILSON, BOBBY L)Sep 26, 2014 - Aug 31, 2020
    NIH
    Center for Biomedical and Health Research Excellence (CBHRE)
    Role: Co-Principal Investigator
    Collapse research resources
    This researcher has shared information about their research resources
    in the eagle-i Network. To update or add resource records, contact
    support@rtrn.net.
    Pharmacology Core

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Edosuyi O, Igbe I, Oyekan A. Fumarate and its downstream signalling pathways in the cardiorenal system: Recent insights and novel expositions in the etiology of hypertension. Eur J Pharmacol. 2023 Dec 15; 961:176186. PMID: 37944846.
      Citations:    Fields:    Translation:HumansCells
    2. Edosuyi O, Choi M, Edosuyi V, Igbe I, Oyekan A. Malate reduced kidney injury molecule (KIM-1) expression and selectively upregulated the renal nitric oxide production in obstructive nephropathy. Bratisl Lek Listy. 2023; 124(2):151-157. PMID: 36598304.
      Citations: 1     Fields:    Translation:Animals
    3. Edosuyi O, Adesuyi A, Choi M, Igbe I, Oyekan A. Malate reduced blood pressure and exerted differential effects on renal hemodynamics; role of the nitric oxide system and renal epithelial sodium channels (ENaC). Eur J Pharmacol. 2023 Jan 05; 938:175441. PMID: 36463945.
      Citations: 2     Fields:    Translation:Animals
    4. Edosuyi O, Choi M, Igbe I, Oyekan A. Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens. 2021 Aug 18; 43(6):555-564. PMID: 33879002.
      Citations: 3     Fields:    Translation:Animals
    5. Ofili EO, Tchounwou PB, Fernandez-Repollet E, Yanagihara R, Akintobi TH, Lee JE, Malouhi M, Garner ST, Hayes TT, Baker AR, Dent AL, Abdelrahim M, Rollins L, Chang SP, Sy A, Hernandez BY, Bullard PL, Noel RJ, Shiramizu B, Hedges JR, Berry MJ, Bond VC, Lima MF, Mokuau N, Kirken RA, Cruz-Correa M, Sarpong DF, Vadgama J, Yates C, Kahn SA, Soliman KF, Perry G, Pezzano M, Luciano CA, Barnett ME, Oyekan A, Kumar D, Norris KC. The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research. Ethn Dis. 2019; 29(Suppl 1):135-144. PMID: 30906162.
      Citations: 16     Fields:    Translation:Humans
    6. Ozurumba E, Mathew O, Ranganna K, Choi M, Oyekan A. Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARa and high salt diet. J Basic Clin Physiol Pharmacol. 2018 Mar 28; 29(2):165-173. PMID: 29500923.
      Citations: 2     Fields:    Translation:AnimalsCells
    7. Alshaman R, Truong L, Oyekan A. Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury. Clin Exp Pharmacol Physiol. 2016 Nov; 43(11):1087-1096. PMID: 27555230.
      Citations: 5     Fields:    Translation:Animals
    8. Dallatu MK, Nwokocha E, Agu N, Myung C, Newaz MA, Garcia G, Truong LD, Oyekan AO. The Role of Hypoxia-Inducible Factor/Prolyl Hydroxylation Pathway in Deoxycorticosterone Acetate/Salt Hypertension in the Rat. J Hypertens (Los Angel). 2014 Dec; 3(6). PMID: 26185735.
      Citations:    
    9. Dallatu MK, Choi M, Oyekan AO. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal. J Hypertens. 2013 Oct; 31(10):2043-9. PMID: 23811999.
      Citations: 7     Fields:    Translation:AnimalsCells
    10. Rizvi YQ, Mehta CS, Oyekan A. Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis. Vascul Pharmacol. 2013 Nov-Dec; 59(5-6):144-51. PMID: 24050945.
      Citations: 8     Fields:    Translation:Animals
    11. Igbe I, Omogbai EK, Oyekan AO. Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics. J Exp Pharmacol. 2013; 5:1-13. PMID: 27186132.
      Citations:    
    12. Oyekan A. PPARs and their effects on the cardiovascular system. Clin Exp Hypertens. 2011; 33(5):287-93. PMID: 21721973.
      Citations: 22     Fields:    Translation:HumansAnimals
    13. Fidelis P, Wilson L, Thomas K, Villalobos M, Oyekan AO. Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. Exp Biol Med (Maywood). 2010 Nov; 235(11):1365-74. PMID: 20943934.
      Citations: 14     Fields:    Translation:AnimalsCells
    14. Yousefipour Z, Oyekan A, Newaz M. Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure. Pharmacol Ther. 2010 Mar; 125(3):436-45. PMID: 20117134.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    15. Newaz M, Yousefipour Z, Oyekan A. Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure. Ren Fail. 2010 Jan; 32(3):384-90. PMID: 20370457.
      Citations: 2     Fields:    Translation:Animals
    16. Yakubu MA, Nsaif RH, Oyekan AO. Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate. Bratisl Lek Listy. 2010; 111(5):258-64. PMID: 20568414.
      Citations: 4     Fields:    Translation:AnimalsCells
    17. Newaz M, Ranganna K, Truong LD, Oyekan A. Effect of peroxisome proliferator-activated receptor-alpha siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet. J Hypertens. 2009 Nov; 27(11):2223-31. PMID: 19834340.
      Citations: 3     Fields:    Translation:AnimalsCells
    18. Yousefipour Z, Oyekan A, Newaz M. Role of G protein-coupled receptor kinase-2 in peroxisome proliferator-activated receptor gamma-mediated modulation of blood pressure and renal vascular reactivity in SHR. Am J Nephrol. 2009; 30(3):201-8. PMID: 19420904.
      Citations: 1     Fields:    Translation:Animals
    19. Banks T, Oyekan A. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat. J Hypertens. 2008 Mar; 26(3):468-77. PMID: 18300857.
      Citations: 9     Fields:    Translation:Animals
    20. Obih P, Oyekan AO. Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice. Blood Press. 2008; 17(1):55-63. PMID: 18568693.
      Citations: 7     Fields:    Translation:Animals
    21. Anozie O, Ross R, Oyekan AO, Yakubu MA. Differential modulation of bradykinin-induced relaxation of endothelin-1 and phenylephrine contractions of rat aorta by antioxidants. Acta Pharmacol Sin. 2007 Oct; 28(10):1566-72. PMID: 17883941.
      Citations: 1     Fields:    Translation:Animals
    22. Yousefipour Z, Hercule H, Truong L, Oyekan A, Newaz M. Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure. J Pharmacol Exp Ther. 2007 Aug; 322(2):461-8. PMID: 17494862.
      Citations: 4     Fields:    Translation:Animals
    23. Yakubu MA, Nsaif RH, Oyekan AO. peroxisome proliferator-activated receptor alpha activation-mediated regulation of endothelin-1 production via nitric oxide and protein kinase C signaling pathways in piglet cerebral microvascular endothelial cell culture. J Pharmacol Exp Ther. 2007 Feb; 320(2):774-81. PMID: 17105827.
      Citations: 8     Fields:    Translation:AnimalsCells
    24. Newaz MA, Yousefipour Z, Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol. 2006 Sep; 48(3):88-94. PMID: 17031261.
      Citations: 17     Fields:    Translation:Animals
    25. Blanton A, Nsaif R, Hercule H, Oyekan A. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. J Hypertens. 2006 Sep; 24(9):1865-72. PMID: 16915037.
      Citations: 8     Fields:    Translation:AnimalsCells
    26. Williams J, Bogwu J, Oyekan A. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J Hypertens. 2006 Jul; 24(7):1429-36. PMID: 16794494.
      Citations: 8     Fields:    Translation:AnimalsCells
    27. Newaz M, Yousefipour Z, Oyekan A. Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure. Pharmacol Res. 2006 Sep; 54(3):234-40. PMID: 16820301.
      Citations: 4     Fields:    Translation:AnimalsCells
    28. Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, Mu W, Oyekan AO, Johnson RJ. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int. 2005 Nov; 68(5):2154-63. PMID: 16221214.
      Citations: 26     Fields:    Translation:Animals
    29. Newaz M, Blanton A, Fidelis P, Oyekan A. NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat Res. 2005 Nov 11; 579(1-2):163-71. PMID: 16054168.
      Citations: 18     Fields:    Translation:Animals
    30. Oyekan AO. Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat. J Pharmacol Exp Ther. 2005 Jun; 313(3):1289-95. PMID: 15769866.
      Citations: 14     Fields:    Translation:Animals
    31. Yakubu MA, Sofola OA, Igbo I, Oyekan AO. Link between free radicals and protein kinase C in glucose-induced alteration of vascular dilation. Life Sci. 2004 Oct 29; 75(24):2921-32. PMID: 15454343.
      Citations: 4     Fields:    Translation:Animals
    32. Newaz MA, Ranganna K, Oyekan AO. Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat. BMC Pharmacol. 2004 Feb 06; 4:1. PMID: 15018640.
      Citations: 15     Fields:    Translation:Animals
    33. Sacerdoti D, Abraham NG, Oyekan AO, Yang L, Gatta A, McGiff JC. Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. J Pharmacol Exp Ther. 2004 Feb; 308(2):636-43. PMID: 14600247.
      Citations: 9     Fields:    Translation:Animals
    34. Sofola O, Yakubu M, Igbo I, Newaz M, Oyekan A. High salt diet modulates cAMP- and nitric oxide-mediated relaxation responses to isoproterenol in the rat aorta. Eur J Pharmacol. 2003 Aug 08; 474(2-3):241-7. PMID: 12921869.
      Citations: 2     Fields:    Translation:Animals
    35. Newaz MA, Yousefipour Z, Hercule H, Truong L, Oyekan A. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection. Clin Exp Hypertens. 2003 Aug; 25(6):335-47. PMID: 12940471.
      Citations:    Fields:    Translation:Animals
    36. Ogungbade GO, Akinsanmi LA, Jiang H, Oyekan AO. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat. Am J Physiol Renal Physiol. 2003 Nov; 285(5):F955-64. PMID: 12865253.
      Citations: 1     Fields:    Translation:AnimalsCells
    37. Hercule HC, Wang MH, Oyekan AO. Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat. J Physiol. 2003 Sep 15; 551(Pt 3):971-9. PMID: 12857783.
      Citations: 9     Fields:    Translation:Animals
    38. Oyekan AO. Contributions of nitric oxide and prostanoids and their signaling pathways to the renal medullary vasodilator effect of U46619 (9-11-dideoxy-11 alpha,9a-epoxymethano-prostaglandin F(2a)) in the rat. J Pharmacol Exp Ther. 2003 Feb; 304(2):507-12. PMID: 12538801.
      Citations: 1     Fields:    Translation:AnimalsCells
    39. Carroll MA, Ferreri NR, Escalante BA, Oyekan AO, McGiff JC. Cytochrome P450 arachidonic acid metabolites modulate renal tubular function. Adv Exp Med Biol. 2003; 525:67-9. PMID: 12751738.
      Citations:    Fields:    Translation:Animals
    40. Oyekan A. Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat. Clin Exp Pharmacol Physiol. 2002 Nov; 29(11):990-5. PMID: 12366390.
      Citations: 2     Fields:    Translation:Animals
    41. Hercule H, Oyekan A. Renal cytochrome p450 oxygenases and preglomerular vascular response to arachidonic acid and endothelin-1 following ischemia/reperfusion. J Pharmacol Exp Ther. 2002 Aug; 302(2):717-24. PMID: 12130736.
      Citations: 5     Fields:    Translation:AnimalsCells
    42. Newaz MA, Oyekan AO. Contribution of renal oxygenases to glycerol-induced acute renal failure in the rat. J Cardiovasc Pharmacol. 2002 Jun; 39(6):834-41. PMID: 12021577.
      Citations:    Fields:    Translation:Animals
    43. Newaz MA, Yousefipour Z, Oyekan A. Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension. Blood Press. 2002; 11(2):110-5. PMID: 12035871.
      Citations:    Fields:    Translation:Animals
    44. Escalante BA, McGiff JC, Oyekan AO. Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule. Am J Physiol Renal Physiol. 2002 Jan; 282(1):F144-50. PMID: 11739122.
      Citations: 13     Fields:    Translation:AnimalsCells
    45. Oyekan AO. Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat. Clin Exp Pharmacol Physiol. 2000 Aug; 27(8):581-6. PMID: 10901386.
      Citations:    Fields:    Translation:Animals
    Oyekan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (216)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support